Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Daniel Martínez-Flores, Jesús Zepeda–Cervantes, Adolfo Cruz-Reséndiz, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 211

Showing 1-25 of 211 citing articles:

Evidence for a mouse origin of the SARS-CoV-2 Omicron variant
Changshuo Wei, Ke-Jia Shan, Wei‐Guang Wang, et al.
Journal of genetics and genomics/Journal of Genetics and Genomics (2021) Vol. 48, Iss. 12, pp. 1111-1121
Open Access | Times Cited: 268
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
Ori Magen, Jacob Waxman, Maya Makov-Assif, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 17, pp. 1603-1614
Open Access | Times Cited: 268
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
Ioannis P. Trougakos, Evangelos Terpos, Harry Alexopoulos, et al.
Trends in Molecular Medicine (2022) Vol. 28, Iss. 7, pp. 542-554
Open Access | Times Cited: 196
Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection
Ariel Israel, Yotam Shenhar, Ilan Green, et al.
Vaccines (2021) Vol. 10, Iss. 1, pp. 64-64
Open Access | Times Cited: 188
GNB3 c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine
Ieva Čiučiulkaitė, Birte Möhlendick, Laura Thümmler, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 132
A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19
Mohsen Heidary, Vahab Hassan Kaviar, Maryam Shirani, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 131
A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 118
SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic
Chiranjib Chakraborty, Manojit Bhattacharya, Kuldeep Dhama
Vaccines (2023) Vol. 11, Iss. 3, pp. 682-682
Open Access | Times Cited: 59
An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines
Fatemeh Bayani, Negin Safaei Hashkavaei, Sareh Arjmand, et al.
Progress in Biophysics and Molecular Biology (2023) Vol. 178, pp. 32-49
Open Access | Times Cited: 40
Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection
Ariel Israel, Yotam Shenhar, Ilan Green, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 94
SARS-CoV-2 Delta (B.1.617.2) Variant: A Unique T478K Mutation in Receptor Binding Motif (RBM) of Spike Gene
Hyunjhung Jhun, Ho‐Young Park, Yasmin Hisham, et al.
Immune Network (2021) Vol. 21, Iss. 5
Open Access | Times Cited: 61
Peptides for Vaccine Development
Ian W. Hamley
ACS Applied Bio Materials (2022) Vol. 5, Iss. 3, pp. 905-944
Open Access | Times Cited: 60
Differences in Clinical Characteristics Between Delta Variant and Wild-Type SARS-CoV-2 Infected Patients
Zhenkui Hu, Xing Huang, Jianguo Zhang, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 58
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
Wei Pang, Ying Lu, Yan‐Bo Zhao, et al.
Cell Research (2022) Vol. 32, Iss. 12, pp. 1068-1085
Open Access | Times Cited: 51
MAIT cells activate dendritic cells to promote TFH cell differentiation and induce humoral immunity
Theresa E. Pankhurst, Kaitlin H. Buick, Joshua Lange, et al.
Cell Reports (2023) Vol. 42, Iss. 4, pp. 112310-112310
Open Access | Times Cited: 29
Timeline of changes in spike conformational dynamics in emergent SARS-CoV-2 variants reveal progressive stabilization of trimer stalk with altered NTD dynamics
Sean M. Braet, Theresa SC Buckley, Varun Venkatakrishnan, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 28
Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges
Sanchita Kar, Popy Devnath, Talha Bin Emran, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 36
Acute Vertigo After COVID-19 Vaccination: Case Series and Literature Review
Paola Di Mauro, Ignazio La Mantia, Salvatore Cocuzza, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 35
Plant‐based expression and characterization of SARS‐CoV‐2 virus‐like particles presenting a native spike protein
Jae-Wan Jung, Gergana Zahmanova, Ivan Minkov, et al.
Plant Biotechnology Journal (2022) Vol. 20, Iss. 7, pp. 1363-1372
Open Access | Times Cited: 32
The SARS-CoV-2 S1 Spike Protein Promotes MAPK and NF-kB Activation in Human Lung Cells and Inflammatory Cytokine Production in Human Lung and Intestinal Epithelial Cells
Christopher B. Forsyth, Lijuan Zhang, Abhinav Bhushan, et al.
Microorganisms (2022) Vol. 10, Iss. 10, pp. 1996-1996
Open Access | Times Cited: 32
An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission
Kairat Tabynov, Nurkeldi Turebekov, Meruert Babayeva, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 28
An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19)
Armina Alagheband Bahrami, Ali Azargoonjahromi, Samin Sadraei, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 27
Nuclear translocation of spike mRNA and protein is a novel feature of SARS-CoV-2
Sarah Sattar, Juraj Kabát, Kailey Jerome, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 18
Incorporation of SARS-CoV-2 spike NTD to RBD protein vaccine improves immunity against viral variants
Isabelle Montgomerie, Thomas W. Bird, Olga R. Palmer, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106256-106256
Open Access | Times Cited: 17
A comprehensive review on the global efforts on vaccines and repurposed drugs for combating COVID-19
Narva Deshwar Kushwaha, Jivanka Mohan, Babita Kushwaha, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115719-115719
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top